Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial
Evan S. Dellon(University of North Carolina at Chapel Hill), Ikuo Hirano(Northwestern University), Lindsay Cortright(University of North Carolina at Chapel Hill), Alina C. Iuga(University of North Carolina at Chapel Hill), Kathryn A. Peterson(University of Utah), Susan E. Moist(University of North Carolina at Chapel Hill), Benjamin Mitlyng(MNGI Digestive Health), Christine Bookhout(University of North Carolina at Chapel Hill), Toby Gee(Leukemia and Lymphoma Society), Swathi Eluri(University of North Carolina at Chapel Hill), Joseph A. Galanko(University of North Carolina at Chapel Hill), John T. Woosley(University of North Carolina at Chapel Hill), Kacie B Walker(University of North Carolina at Chapel Hill), Brenderia A. Cameron(University of North Carolina at Chapel Hill), Sarah J. McGee(University of North Carolina at Chapel Hill)
Cited by 89
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k